Description
An inhibitor of HMG-CoA reductase (Ki = 1.3 nM); inhibits cholesterol synthesis in and growth of human arterial myocytes (IC50s = 0.4 and 4.6 nM, respectively); inhibits cholesterol biosynthesis in rats and dogs (ED50 = 0.002 mg/kg for both); reduces serum levels of cholesterol, triglycerides, and LDL in dogs in a dose-dependent manner; decreases cholesterol ester accumulation in arterial tissue of rabbits fed a 0.2% cholesterol diet (0.1 mg/kg); stabilizes plaques and delays progression into atherosclerotic disease in LDL-receptor deficient rabbits with hypercholesterolemia,,
Formal name: (3R,5S,6E)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-bis(1-methylethyl)-3-pyridinyl]-3,5-dihydroxy-6-heptenoic acid, monosodium salt
Synonyms: BAY-w 6228
Molecular weight: 481.5
CAS: 143201-11-0
Purity: ≥98%
Formulation: A solid
Product Type|Biochemicals|Small Molecule Inhibitors|Sterol Biosynthesis||Research Area|Cardiovascular System|Blood|Acute Phase Reactants||Research Area|Cardiovascular System|Blood|Serum Proteins||Research Area|Cardiovascular System|Cardiovascular Diseases|Atherosclerosis||Research Area|Cardiovascular System|Lipids & Lipoproteins|Cholesterol Metabolism||Research Area|Cardiovascular System|Lipids & Lipoproteins|Lipoproteins||Research Area|Cardiovascular System|Vasculature|Angiogenesis||Research Area|Cardiovascular System|Vasculature|Smooth Muscle Cells